Flourishing trade activity in life science industry

The life science industry has had a handful of business trades in the year's first month and a half. There's a high level of activity, industry sources tell MedWatch.

Photo: Colourbox

In the last two months or so, business trade activity has flourished in the life science industry with a series of Danish companies getting new ownership.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs